a.ibarra

TL2 · Funchal

Contributes reviews on supplier material. Based in Funchal.

Joined 13 December 2024 · last posted 4d

84 posts, newest first. Showing up to 150.

What a good consultation looks like from the other side Replied, post #62 · Clinical › Prescriber conversations · 24 Jul 2026 · 11 likes Coming back to post #60, because the follow-up matters more than the original answer. Written summaries after an appointment are available in many systems and are worth…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #66 · Practice › Dosing & titration · 21 Jul 2026 · 10 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #56 · Practice › Interactions · 17 Jul 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #44 · Compounds › Retatrutide · 17 Jul 2026 · 5 likes A request rather than an answer: could whoever has the primary source for TRIUMPH post it? I have seen the claim three times this month and each version had lost a…
Pages past their review date, listed — does this still hold? Replied, post #48 · Meta › Wiki maintenance · 11 Jul 2026 · 25 likes Post #44 describes the usual case. This is about the unusual one. Pages past: I would want to see the raw numbers rather than the summary before agreeing. Summaries…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #39 · Compounds › Retatrutide · 5 Jul 2026 · 17 likes A theoretical mass for retatrutide is not published in the peer-reviewed literature in a form worth quoting. A report should state the mass observed on the instrument…
How much context is too much context in a first post? Replied, post #6 · Start Here › How to Ask · 4 Jul 2026 · 31 likes Building on post #5 rather than restating it. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #11 · Compounds › Repair & healing peptides · 3 Jul 2026 · 0 likes Post #9 is the version of this I will quote in future. One addition. The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not…
Angle of injection and whether 90 degrees is always right — the long version Replied, post #29 · Practice › Administration · 22 Jun 2026 · 12 likes Coming back to post #25, because the follow-up matters more than the original answer. Pinch or no pinch: the decision depends on needle length and on your own anatomy.…
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #17 · Sourcing › Vendor reports · 19 Jun 2026 · 0 likes Post #15 put the caveat in the right place and I want to underline it. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because…
Follow-up: Sleep quality changes during weight loss Replied, post #48 · Wellbeing › Sleep · 18 Jun 2026 · 33 likes Sleep-disordered breathing improving with weight reduction is one of the better-evidenced downstream effects, and the trial that measured it used an objective index…
When a dose reduction is the correct response to a side effect Replied, post #30 · Practice › Dosing & titration · 16 Jun 2026 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #36 · Start Here › How to Ask · 12 Jun 2026 · 9 likes This follows post #35 rather than contradicting it. Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on…
Reading a trial's population section before its results Replied, post #105 · Evidence › Trials · 9 Jun 2026 · 8 likes Coming back to post #103, because the follow-up matters more than the original answer. Generalisability: the enrolled population was selected in ways that matter. Entry…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #82 · Practice › Storage & stability · 7 Jun 2026 · 9 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #77 · Evidence › Journal club · 5 Jun 2026 · 9 likes Thank you for taking the time. That was more work than a reply usually is.
Pages past their review date, listed — does this still hold? Replied, post #2 · Meta › Wiki maintenance · 3 Jun 2026 · 16 likes Requesting a review date change rather than a content change. This page is being read far more than it was and the annual cycle is now too slow for it. I keep a log of…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #55 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 8 likes Two questions I would want answered before drawing anything from the peak-to-trough ratio data above: how were the cases selected, and what happened to the ones that…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #25 · Analytics › Method validation · 3 Jun 2026 · 22 likes The honest answer on specificity is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
Blind submission and why it changes minds — the long version Replied, post #97 · Sourcing › Independent verification · 25 May 2026 · 12 likes I read post #93 twice before replying, because I had assumed the opposite. The confident answers on Blind submission and the well-sourced answers are not the same…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #65 · Sourcing › Vendor reports · 11 May 2026 · 10 likes Post #62 is right about the mechanism and I think understates the practical bit. Do not adjust a reported figure. Post what the laboratory said and put your…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #132 · Pharmacology › Pharmacokinetics · 6 May 2026 · 1 like I will take the caveat as seriously as the claim, which is the point of putting it there.
Pancreatitis history and the risk calculus Replied, post #5 · Safety › Contraindications · 24 Apr 2026 · 25 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Replied, post #4 · Compounds › Secretagogues & GH axis · 23 Apr 2026 · 17 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
Managing an unplanned gap in supply Replied, post #104 · Access › Shortages · 20 Apr 2026 · 21 likes Both are useful and different. The notice tells you the national position; the account tells you what is happening on the ground.
Revisiting: Drawing up with one needle and injecting with another Replied, post #51 · Practice › Administration · 5 Apr 2026 · 27 likes Appreciated. The plain phrasing does more work here than a longer post would.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #22 · Evidence › Preprints · 2 Apr 2026 · 30 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight.
[2026 update] What a good consultation looks like from the other side Replied, post #20 · Clinical › Prescriber conversations · 11 Mar 2026 · 7 likes Small methodological point on good consultation: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Personal import allowances, compared — a second dataset Replied, post #80 · Access › International · 6 Mar 2026 · 27 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #50 · Analytics › Method validation · 21 Feb 2026 · 2 likes No disagreement from me. Posting only so the question does not look ignored.
Interpreting a result that disagrees with the supplier's certificate Replied, post #93 · Sourcing › Independent verification · 24 Jan 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. That much is documented. The rest is how I…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #14 · Regional › UK & Ireland · 26 Dec 2025 · 26 likes Post #12 and I disagree about the size of the effect, not about the direction. What I want from this Private prescribing thread is the list of things that would need to…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #91 · Compounds › Oral incretins · 14 Dec 2025 · 16 likes Adding the measurement that post #90 says would settle it. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and…
Tracking a preprint to publication: a worked example Replied, post #84 · Evidence › Preprints · 8 Dec 2025 · 14 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it. Happy…
Airline travel with a temperature-sensitive injectable Replied, post #20 · Devices › Cold chain · 6 Dec 2025 · 23 likes Narrowing post #17, because the general version has more than one answer. Recording arrival condition on ordinary deliveries is what makes the record useful. A file…
Cross-border purchase rules within the EU Replied, post #46 · Regional › European Union · 29 Nov 2025 · 13 likes Answering the question post #45 raises rather than the one it answers. Nothing here is medical or legal advice, and this subcategory in particular attracts questions…
Tracking that stops updating and then resumes Replied, post #50 · Sourcing › Logistics · 27 Nov 2025 · 3 likes Post #48 describes the usual case. This is about the unusual one. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #19 · Outcomes › Body composition · 24 Nov 2025 · 4 likes The arithmetic in post #16 is right; the assumption feeding it is the part to check. Speaking only to Circumference measurements as I have actually seen it, rather than…
Pen dose counters: what a click does and does not guarantee Replied, post #103 · Devices › Pens & autoinjectors · 19 Nov 2025 · 13 likes Post #99 and I disagree about the size of the effect, not about the direction. A pen that will not dial to the intended dose is usually telling you the cartridge does…
What pooling buys you and what it destroys Replied, post #69 · Evidence › Meta-analyses · 18 Nov 2025 · 0 likes I had written a reply contradicting post #67 and deleted it. Here is what survived. Double extraction with disagreement resolution is standard and is worth checking…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #92 · Compounds › Tirzepatide · 17 Nov 2025 · 2 likes On post #89 — agreed on the reasoning, with one qualification. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #77 · Compounds › Tirzepatide · 15 Nov 2025 · 11 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
Critiquing an observational claim about a class effect — one year on Replied, post #8 · Evidence › Study critique · 1 Nov 2025 · 0 likes Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters.
Waist circumference technique and its repeatability Replied, post #7 · Outcomes › Progress reports · 15 Oct 2025 · 3 likes Checked the waist circumference technique claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
Insurance and replacement policies, compared — the long version Replied, post #26 · Sourcing › Logistics · 13 Oct 2025 · 22 likes I changed my mind about Insurance and replacement policies after someone here asked me for the source and I could not produce one. That is worth saying out loud because…
Micronutrient adequacy at low total intake — does this still hold? Replied, post #18 · Nutrition & Training › Protein & intake · 7 Oct 2025 · 0 likes The arithmetic in post #17 is right; the assumption feeding it is the part to check. Renal considerations around higher protein intake apply to people with existing…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #27 · Practice › Interactions · 5 Oct 2025 · 9 likes Where I would push back on the Warfarin and altered intake consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Follow-up: Why appetite effects are mostly central Replied, post #58 · Pharmacology › Receptor biology · 4 Oct 2025 · 31 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
Second pass at: Programming during a large energy deficit Replied, post #23 · Nutrition & Training › Resistance training · 30 Sep 2025 · 0 likes Narrowing post #22, because the general version has more than one answer. Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for…
Substitution between formats during a shortage Replied, post #64 · Access › Shortages · 27 Sep 2025 · 5 likes Post #63 and I disagree about the size of the effect, not about the direction. Shortage status determines what compounding is permitted in some jurisdictions, which…
High-resolution MS on aggregates and what it can see Replied, post #77 · Analytics › Mass spectrometry · 26 Sep 2025 · 3 likes That is clearer than the version I had in my head. Thank you.
Reading SURMOUNT-1 without the press release Replied, post #9 · Compounds › Tirzepatide · 15 Sep 2025 · 21 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #35 · Practice › Side effects · 3 Sep 2025 · 11 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
When a preprint is the best available evidence and we say so Replied, post #103 · Evidence › Preprints · 27 Aug 2025 · 1 like Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful. It is the sort of thing…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #27 · Evidence › Journal club · 18 Aug 2025 · 2 likes Post #26 is right about the mechanism and I think understates the practical bit. Bringing the previous paper on the same question makes the session much better and…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #16 · Analytics › HPLC & UHPLC · 24 Jul 2025 · 31 likes Worth stating the null on Resolution and tailing factor before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not…
A field-by-field walk through a certificate of analysis Replied, post #146 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes Post #144 is the version of this I will quote in future. One addition. My experience of field-by-field walk through a certificate contradicts the reply above. I am…
Managing an unplanned gap in supply — what changed since Replied, post #13 · Access › Shortages · 8 Jul 2025 · 28 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #82 · Clinical › Comorbidities · 4 Jul 2025 · 0 likes Practical note on hepatic steatosis: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would…
Repeatability versus intermediate precision Replied, post #3 · marked as the solution · Analytics › Method validation · 16 Jun 2025 · 7 likes The opening post put the caveat in the right place and I want to underline it. Agreed on repeatability versus intermediate precision, with one qualification that I…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #33 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 5 likes Answering the question post #29 raises rather than the one it answers. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding…
What a 2 ppm match establishes, and what it does not Replied, post #22 · Analytics › Mass spectrometry · 1 Jun 2025 · 12 likes I read post #20 twice before replying, because I had assumed the opposite. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS,…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #23 · Evidence › Trials · 4 May 2025 · 11 likes Everything in post #19 holds. The case it does not cover is the one I have. Confounding in observational data: a third variable can explain an apparent association. In…
Scheduled maintenance and what will be unavailable Replied, post #113 · Meta › Announcements · 17 Apr 2025 · 5 likes On post #110 — agreed on the reasoning, with one qualification. Agreed on scheduled maintenance, with one qualification that I think matters. The reasoning holds for…
Validating a calculator against hand arithmetic — what changed since Replied, post #19 · Data & Tools › Calculators · 16 Apr 2025 · 13 likes Nothing a calculator produces is medical advice, and a correct calculation on inappropriate inputs is still an inappropriate answer.
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #42 · Practice › Interactions · 9 Apr 2025 · 0 likes I had written a reply contradicting post #40 and deleted it. Here is what survived. Where a published interaction study exists it usually reports an area-under-curve…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #30 · Practice › Reconstitution · 30 Mar 2025 · 14 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #116 · Sourcing › Regulatory · 29 Mar 2025 · 30 likes I had written a reply contradicting post #114 and deleted it. Here is what survived. Generic or biosimilar entry depends on patent and exclusivity positions that are…
Talking to a therapist about this specifically — does this still hold? Replied, post #31 · Wellbeing › Mental health · 17 Mar 2025 · 22 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well. That is all I can say without…
Consistent declarations and why they matter more than clever ones Replied, post #92 · Sourcing › Logistics · 26 Feb 2025 · 0 likes On post #90 — agreed on the reasoning, with one qualification. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #2 · Wellbeing › Mental health · 8 Feb 2025 · 19 likes I would rather this thread reach "we do not know" about Mood changes than reach a confident answer that nobody can support when asked.
Sample size in a voluntary survey: the selection problem Replied, post #4 · Data & Tools › Datasets · 29 Jan 2025 · 0 likes Worth separating two things that post #3 runs together. Aggregating first-hand accounts does not produce evidence of the kind a trial produces. It produces a…
What changed in 2026, by region Replied, post #40 · Access › International · 25 Dec 2024 · 2 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
Request: a diff view for wiki revisions Replied, post #28 · Meta › Feature requests · 3 Dec 2024 · 0 likes Request from the analytics side: allow a table in a post to be marked as data rather than layout, so it can be copied without the formatting. Half the tables here are…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #12 · Meta › Wiki maintenance · 19 Oct 2024 · 0 likes Since revision dispute resolved keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #104 · Clinical › Bloodwork · 13 Oct 2024 · 0 likes Whatever the answer on bring a laboratory turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
Requesting a page: what makes a good request — what changed since Replied, post #77 · Documentation › Wiki requests · 11 Oct 2024 · 13 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #110 · Sourcing › Independent verification · 5 Oct 2024 · 8 likes An observation about Splitting a vial that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #72 · Practice › Administration · 2 Oct 2024 · 30 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
[2026 update] Comparing tirzepatide and semaglutide is harder than the tables suggest Replied, post #2 · Compounds › Tirzepatide · 3 Sep 2024 · 1 like The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
Correlation in a self-tracked dataset: what it can support Replied, post #110 · Research Methods › Statistics · 24 Aug 2024 · 19 likes I read post #108 twice before replying, because I had assumed the opposite. Correlation is a question about a distribution, not about a value, and treating it as a…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #38 · Nutrition & Training › Hydration & electrolytes · 13 Aug 2024 · 15 likes Post #34 put the caveat in the right place and I want to underline it. I would rather this thread reach "we do not know" about Sodium than reach a confident answer that…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #18 · Compounds › Retatrutide · 16 Jul 2024 · 24 likes Where I part company with post #14, and it is a narrow parting. Whether triple agonism is additive or synergistic is an open question and the published work does not…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #56 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes I have been on both sides of the Splitting a weekly dose argument in this category within eighteen months, which should tell you how strong the evidence for either side…